BPC-157 vs TB-500: Which Recovery Peptide Do Researchers Prefer
Additionally, a randomized, double-blind, placebo-controlled trial in 2,588 healthy older adults with mild hyperhomocysteinemia found that daily supplementation with 500 g of vitamin B 12 and 400 g of folic acid for two years reduced blood homocysteine concentrations but had no benefit on depressive symptoms in those with or without depressive symptoms at baseline (110)
BPC-157 (Body Protection Compound-157) is a synthetic, stable peptide of 15 amino acids (sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with a molecular weight of approximately 1,419 Daltons
PMCID: PMC5985336 Ritelli M, Cinquina V, Venturini M, Pezzaioli L, Formenti AM, Chiarelli N, Colombi M
Apex Biopharma
Standard titration schedule The protocol used in phase 2 and phase 3 clinical trials follows this pattern: Each dose step lasts four weeks